Follow
Istvan Edes
Istvan Edes
Professor of Cardiology, Institute of Cardiology, University of Debrecen, Hungary
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
57632013
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and …
WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ...
European heart journal 28 (20), 2539-2550, 2007
38602007
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre …
European Trial on Reduction of Cardiac Events with Perindopril in Stable ...
The Lancet 362 (9386), 782-788, 2003
30302003
The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial
P Lechat, KW Brunhuber, R Hofmann, P Kuhn, HJ Nesser, J Slany, ...
Lancet 353 (9146), 9-13, 1999
24231999
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
12182008
Cardiomyocyte stiffness in diastolic heart failure
A Borbély, J Van Der Velden, Z Papp, JGF Bronzwaer, I Edes, ...
Circulation 111 (6), 774-781, 2005
6792005
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
6752018
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth, J Boczán, N Kedei, E Lizanecz, Z Bagi, Z Papp, I Édes, L Csiba, ...
Molecular Brain Research 135 (1-2), 162-168, 2005
5072005
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium
A Borbély, I Falcao-Pires, L van Heerebeek, N Hamdani, I Edes, C Gavina, ...
Circulation research 104 (6), 780-786, 2009
4352009
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ...
International journal of cardiology 159 (2), 82-87, 2012
3732012
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
E Kiss, G Jakab, EG Kranias, I Edes
Circulation research 75 (2), 245-251, 1994
3641994
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
M Gyöngyösi, W Wojakowski, P Lemarchand, K Lunde, M Tendera, ...
Circulation research 116 (8), 1346-1360, 2015
3402015
Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca2+ Sensitivity of Cardiac Myofibrils and …
I Edes, E Kiss, Y Kitada, FM Powers, JG Papp, EG Kranias, RJ Solaro
Circulation research 77 (1), 107-113, 1995
3021995
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo …
HA Ghofrani, G Simonneau, AM D'Armini, P Fedullo, LS Howard, X Jaďs, ...
The Lancet Respiratory Medicine 5 (10), 785-794, 2017
2872017
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
2422019
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ...
European heart journal 38 (9), 648-660, 2017
2222017
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
1992019
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations
MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ...
International journal of cardiology 191, 256-264, 2015
1952015
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Z Papp, K Csapó, P Pollesello, H Haikala, I Édes
Cardiovascular drug reviews 23 (1), 71-98, 2005
1842005
Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial
M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ...
Journal of the American College of Cardiology 73 (4), 387-396, 2019
1832019
The system can't perform the operation now. Try again later.
Articles 1–20